Affordable Access

Publisher Website

Study of the muscarinic receptor subtypes in N1E 115 mouse neuroblastoma cells

Pharmacological Research
Publication Date
DOI: 10.1016/s1043-6618(05)80103-3
  • Biochemical And Molecular Pharmacology


Summary Muscarinic receptors in N1E 115 mouse neuroblastoma cells were characterized by competition binding experiments using three agonists and five antagonists, including 4-DAMP and AF-DX 116, and by studying the effect of agonist stimulation on the cellular cAMP and cGMP content. The results of the binding studies with the antagonists suggest that only one single homogeneous binding site of the M 1 muscarinic receptor subtype is present. For the binding with the agonists, two binding sites were detected, one with high affinity for the ligand (between 53 and 77% of the total binding sites depending on the agonist) and one with low affinity. In contrast to the results obtained with the binding experiments using antagonists, the study of the cellular cyclic nucleotide response upon carbachol stimulation suggested the presence of both the M 1 and M 2 subtypes as there was an increase in cyclic GMP concentration while at the same time, the prostaglandin-stimulated synthesis of cyclic AMP was inhibited. Considering both binding and functional data we suggest that in N1E 115 cells a majority of M 1 and a minority of M 2 muscarinic receptors are present; there is no evidence for the presence of M 3 muscarinic receptors.

There are no comments yet on this publication. Be the first to share your thoughts.